MarginsXMarginsX
Home › Markets › Health Care › AEMD

Aethlon Medical Inc. (AEMD)

AEMD trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$5.01
-5.29% on the day
Market cap
$8.1M
Nano cap
Revenue · 2023
$0
-100.0% on 2022
Net income · 2023
-$12.2M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2024-03-31, https://www.sec.gov/Archives/edgar/data/882291/000168316824004530/0001683168-24-004530-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2024-03-31.

Profile

FieldValue
TickerAEMD on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000882291
SEC industry codePharmaceutical Preparations
Incorporated inNV

Financials · 2023

LineValue
Revenue$0
Net income-$12.2M
Operating income-$12.6M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growth-100.0%
Cash$5.4M
Total assets$8.2M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
10.7 months
$6.5M cash at September 30, 2026
Share count, 1 year
+955.6%
2025-11-10 to 2026-11-12 · +25691.0% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.
"Based on its assessment, management concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for at least twelve months from the date these financial statements are issued."
10-Q 2026-11-12
Cash and burn$6.5M cash; operating cash flow -$1.8M a quarter.Report 2026-09-30
Shares outstanding1,607,367 (2026-11-12); 761,318 a year earlier; 2,492,908 three years earlier. 1y figure adjusted for splits (1-for-5 overall); 3y figure adjusted for splits (1-for-400 overall).Cover page 2026-11-12
Reverse splits, 3 years3; latest 1-for-5 on 2026-08-04Source 2026-08-04
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-06-04
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorHaskell & White LLP, Irvine, California, United StatesPCAOB Form AP 2026-06-10
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2027
2026-09-30
Not filed-$2.6M-$1.7M$6.5MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2027
2026-06-30
Not filed-$1.5M-$1.9M$4.9MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2026
2026-03-31
Not filed-$1.9M-$1.8M$5.0MNo debt tagsNeeds four quarters10-K 2026-06-10
Q3 2026
2025-12-31
Not filed-$2.0M-$1.9M$7.0MNo debt tagsNeeds four quarters10-Q 2026-02-12
Q2 2026
2025-09-30
Not filed-$1.5M-$1.7M$5.9MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q1 2026
2025-06-30
Not filed-$1.8M-$1.7M$3.8MNo debt tagsNeeds four quarters10-Q 2026-11-12
Q4 2025
2025-03-31
Not filed-$6.3M-$1.7M$5.5MNo debt tagsNeeds four quarters10-K 2026-06-10
Q3 2025
2024-12-31
Not filed-$1.8M-$2.0M$4.8MNo debt tagsNeeds four quarters10-Q 2026-02-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32026-07-07
Latest annual report
FORM 10-K FOR MAR 2026
10-K2026-06-10
Latest quarterly / interim
FORM 10-Q FOR SEP 2026
10-Q2026-11-12
Latest current report
CURRENT REPORT
8-K2026-11-16
Latest proxy
FORM DEFA14A
DEFA14A2026-09-04

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-3.3%
1 month-5.2%
3 months+80.5%
Year to date-61.8%
1 year-77.7%
From 52-week high-78.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
ARAYAccuray Incorporated$2.55-8.93%$7.7M
PLSMPulsenmore Ltd.$1.41+2.17%$9.2M
CNSYCerenome Inc. Common Stock$0.7148-24.77%$7.0M
NMTCNeuroOne Medical Technologies Corporation$0.7450-0.01%$6.8M
SINTSiNtx Technologies Inc.$1.34-1.11%$10.1M
FEMYFemasys Inc.$1.28-8.57%$11.1M
WOKWORK Medical Technology Group LTD$1.23+2.50%$5.5M
DRIODarioHealth Corp.$1.15-8.73%$13.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier